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The impact of high-flux hemodialysis on clinical outcomes
remains controversial. We have previously shown that in vivo
transmigrated leukocytes from patients with low-flux
bioincompatible hemodialysis have an impaired capacity to
upregulate CD11b at the site of interstitial inflammation. In the
present study, we investigated the in vivo capacity of
transmigrated monocytes and granulocytes to express CD11b
at the site of interstitial inflammation in 10 patients on
biocompatible high-flux hemodiafiltration or high-flux
hemodialysis and 12 healthy subjects, and the in vitro response
to a bacteria-related peptide (N-formyl-methionyl-leucyl-
phenylalanine (fMLP)). Leukocyte formation of hydrogen
peroxide (H2O2) and leukocyte apoptosis were also studied. In
patients, both monocytes and granulocytes had a preserved
capacity to express CD11b following in vivo transmigration to
sites of interstitial inflammation, compared with cells from
healthy subjects. Furthermore, monocytes and granulocytes
from patients showed a preserved ability to respond to
challenge with fMLP in the extravascular milieu. The
intracellular killing capacity of leukocytes (H2O2 production) in
the interstitium was similar as of cells from healthy subjects
both before and after stimulation with fMLP. Following
maximal receptor independent stimulation (phorbol 12-
myristate 13-acetate), leukocytes from patients showed lower
H2O2 production at the site of intense inflammation, compared
with cells from healthy subjects. Finally, leukocyte apoptosis in
interstitial inflammation was similar in patients and healthy
subjects. We conclude that in vivo transmigrated leukocytes
from patients on biocompatible high-flux hemodiafiltration or
high-flux hemodialysis have a preserved capacity to express
CD11b at the site of interstitial inflammation. This may have
important biological implications.
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Infection is a common cause of morbidity and mortality in
patients with end stage renal disease1–3 and mortality due to
sepsis occurs much more commonly among hemodialysis
patients than in the general population.4 The enhanced
susceptibility to infection is multifactorial. Major contribut-
ing factors are metabolic and functional abnormalities of
leukocytes caused by accumulation of uremic toxins that
inhibit leukocyte function and bioincompatibility of the
dialysis procedure.5–9 Previous studies have shown that
specific uremic retention solutes have inhibitory effects on
immune-competent cells.10,11 Apart from this, several reports
have demonstrated altered leukocyte adherence to endothelial
cells, impaired phagocytosis and chemotaxis, altered genera-
tion of reactive oxygen species and impaired intracellular
killing of bacteria.12
The recruitment of circulating leukocytes into inflamed
tissues depends on interaction between adhesion molecules
on leukocytes and vascular endothelial cells. Tethering
brings the leukocyte into transient contact with the vessel
wall allowing it to sample the endothelium for the presence
of factors that activate a secondary phase of integrin-
mediated adhesion, before transmigration into the extra-
cellular matrix of the tissue.13 Chemokines contribute to
leukocyte recruitment firstly by activating integrins and
secondly by promoting the migration of adherent leukocytes
across the endothelium and through the extracellular
matrix.14
We have previously studied leukocyte activation and
transmigration into induced sites of inflammation in the
interstitium in patients with low-flux bioincompatible
hemodialysis, by use of a skin suction chamber techni-
que.15,16 In vivo transmigrated monocytes and granulocytes
from patients with low-flux hemodialysis showed an
impaired capacity to upregulate the adhesion molecule
CD11b in response to interstitial inflammation. CD11b is
important for leukocyte function in terms of phagocytosis
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and an impaired response might contribute to an
increased susceptibility to infections observed in this group
of patients.
A number of previous studies have suggested that type of
dialysis membrane (low-flux or high-flux) is associated with
differences in long-term outcome of patients undergoing
hemodialysis, both in terms of morbidity and mortality.17–20
One controlled clinical study demonstrated that synthetic
high-flux dialyzers were associated with improvement in
neutrophil function in the peripheral circulation.21 We
therefore aimed at investigating the in vivo capacity of
transmigrating monocytes and granulocytes to upregulate
CD11b in response to an induced interstitial inflammation in
patients treated with biocompatible high-flux hemodiafiltra-
tion or high-flux hemodialysis. Furthermore, leukocyte
intracellular killing capacity and leukocyte apoptosis were
studied at the site of interstitial inflammation. We hypothe-
sized that high-flux treatment preserves leukocyte perfor-
mance at the actual site of function, namely at the
extravascular site in the interstitium.
RESULTS
There were no significant differences in the number of
monocytes and granulocytes in the peripheral circulation or
at the sites of interstitial inflammation between patients and
healthy subjects at any time point.
Expression of CD11b on monocytes
There were no significant differences in the expression of
CD11b on monocytes in the peripheral circulation between
patients and healthy subjects at times 0 and 10 h (Table 1).
The baseline expression of CD11b at 41C was three to five
times higher on in vivo transmigrated monocytes in the
intact skin blister at 0 h compared with in the peripheral
circulation in both patients and healthy subjects (Po0.01
for both comparisons). There were no significant differences
in the expression of CD11b on monocytes in patients
and healthy subjects at the three sites of interstitial
inflammation. In addition, the increase in CD11b expression
following transmigration was similar in patients and healthy
subjects.
In vitro activation of monocytes with N-formyl-methio-
nyl-leucyl-phenylalanine (fMLP) induced a significant in-
crease in the CD11b expression on cells in the peripheral
circulation and at the three sites of interstitial inflammation
in both patients and healthy subjects (Table 1). The fMLP-
induced increase in CD11b on monocytes in the peripheral
circulation was similar in patients and healthy subjects both
at time 0 h and at time 10 h. The CD11b expression on
monocytes following fMLP stimulation was similar in cells
from patients and healthy subjects both in the intact blister at
time 0 h and at the sites of intermediate and intense
inflammation (Table 1).
Expression of CD11b on granulocytes
The expression of CD11b on granulocytes in the peripheral
circulation was similar in patients and healthy subjects at
time 0 and 10 h (Table 2). In vivo transmigration of
granulocytes to induced sites of interstitial inflammation
induced a two to four times higher expression of CD11b
compared with cells in the peripheral circulation (Po0.01),
which was similar in patients and healthy subjects. There
were no significant differences in the baseline granulocyte
CD11b expression at 41C between granulocytes from patients
and healthy subjects at the three sites of interstitial
inflammation (Table 2).
Stimulation of granulocytes with fMLP induced a
significant increase in the expression of CD11b on cells in
the peripheral circulation, both in patients and healthy
subjects (Table 2). There were no significant differences in the
upregulation of CD11b on granulocytes at the three sites of
interstitial inflammation following challenge with fMLP
between patients and healthy subjects.
Respiratory burst (H2O2 production)
Hydrogen peroxide (H2O2) production of monocytes in the
peripheral circulation at time 0 h was similar in patients and
healthy subjects (Table 1). The H2O2 production was slightly
higher of monocytes in the peripheral circulation at 10 h in
patients compared with cells from healthy controls
(P¼ 0.051). Following stimulation with fMLP or phorbol
12-myristate 13-acetate (PMA), there were no significant
differences in the H2O2 production of monocytes in the
peripheral circulation in patients and healthy subjects
(Table 1).
At the site of intermediate inflammation, the H2O2
production of monocytes was similar in patients and healthy
subjects both before and following stimulation with fMLP or
PMA (Table 1). At the site of intense inflammation, the H2O2
production of monocytes was higher in cells from healthy
subjects compared with cells from patients (Po0.05).
Similarly, the H2O2 production following stimulation with
fMLP or PMA was higher in monocytes from healthy subjects
compared with in cells from patients at the site of intense
inflammation (Po0.05, Table 1).
In the peripheral circulation at 0 and 10 h and at the site of
intermediate inflammation in the interstitium, the H2O2
production of granulocytes from patients was similar as in
cells from healthy subjects (Table 2). At the site of intense
inflammation, the H2O2 production of granulocytes from
patients was significantly lower than from granulocytes from
healthy subjects. In addition, granulocytes from patients
showed an impaired response to fMLP at the site of intense
inflammation in terms of H2O2 production compared with
cells from healthy subjects. Following the most potent
receptor-independent stimulation with PMA, granulocytes
from patients showed an impaired response in terms of H2O2
production both in the peripheral circulation and at the sites
of interstitial inflammation compared with cells from healthy
subjects (Table 2).
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Table 1 | Monocyte CD11b expression at 41C and following stimulation with fMLP (mean7s.d.); respiratory burst unstimulated
and following stimulation with fMLP or PMA (median and range) in the peripheral circulation and at the sites of interstitial
inflammation
Peripheral circulation Interstitial inflammation
0 h 10 h 0 h Intermediate Intense
CD11b expression (41C, MFI)
Patients 8.672.2 10.675.4 31.272.7 35.178.7 29.776.6
Healthy subjects 7.272.2 8.273.6 38.876.2 41.9711.2 40.4712.5
P (ANOVA) NS NS NS NS NS
CD11b expression following fMLP (MFI)
Patients 46.6711.6 53.5716.9 62.4710.3 62.1717.2 58.8717.2
Healthy subjects 57.5718.7 65.5713.8 76.4717.3 84.2720.7 76.8718.3
P (ANOVA) NS NS NS NS NS
Respiratory burst (MFI)
Patients 5.5 (1.4–18.7) 7.9 (2.5–29.9) NE 17.8 (2.6–61.2) 1.4 (0.6–4.5)
Healthy subjects 3.8 (2.3–5.7) 3.6 (2.4–7.6) NE 3.5 (1.3–6.7) 4.1 (0.5–6.6)
P (Mann–Whitney U-test) NS 0.051 0.088 o0.05
Respiratory burst (fMLP, MFI)
Patients 7.4 (2.3–20.4) 8.9 (1.7–35.8) NE 23.7 (2.6–66.5) 1.8 (0.6–15.9)
Healthy subjects 6.6 (4.8–13.6) 6.2 (4.1–12.4) NE 9.4 (3.6–28.6) 7.7 (0.8–29.8)
P (Mann–Whitney U-test) NS NS NS o0.05
Respiratory burst (PMA, MFI)
Patients 53.9 (14.1–70.4) 55.1 (21.3–76.7) NE 19.8 (6.8–51.5) 9.6 (3.4–30.5)
Healthy subjects 48.9 (37.2–157.3) 53.1 (35.4–139.8) NE 15.2 (6.1–43.7) 26.1 (1.8–57.7)
P (Mann–Whitney U-test) NS NS NS o0.05
ANOVA, analysis of variance; fMLP, formyl-methionyl-leucyl-phenylalanine; MFI, mean fluorescence intensity; NE, not examined; NS, nonsignificant; PMA, phorbol 12-myristate
13-acetate.
Table 2 | Granulocyte CD11b expression at 41C and following stimulation with fMLP (mean7s.d.); respiratory burst
unstimulated and following stimulation with fMLP or PMA (median and range) in the peripheral circulation and at the sites of
interstitial inflammation
Peripheral circulation Interstitial inflammation
0 h 10 h 0 h Intermediate Intense
CD11b expression (41C, MFI)
Patients 7.774.1 6.772.2 37.273.5 54.9713.8 47.178.4
Healthy subjects 5.072.2 5.371.3 33.979.3 68.9718.1 65.4713.3
P (ANOVA) NS NS NS NS NS
CD11b expression following fMLP (MFI)
Patients 82.3715.6 93.2720.6 120.0724.5 115.9727.8 107.5729.8
Healthy subjects 96.6742.1 96.3732.4 111.4739.3 144.1731.2 128.6726.4
P (ANOVA) NS NS NS NS NS
Respiratory burst (MFI)
Patients 6.0 (1.1–23.7) 6.6 (1.4–25.3) NE 23.5 (2.7–84.1) 3.1 (0.15–9.7)
Healthy subjects 2.7 (1.6–3.6) 2.4 (1.6–4.4) NE 6.7 (4.2–12.0) 7.9 (5.1–20.8)
P (Mann–Whitney U-test) NS NS NS o0.05
Respiratory burst (fMLP, MFI)
Patients 19.3 (3.1–46.8) 18.2 (3.1–72.0) NE 40.2 (3.7–97.7) 5.7 (0.3–31.4)
Healthy subjects 18.6 (10.3–33.2) 15.2 (10.5–34.2) NE 22.9 (15.8–25.5) 19.8 (14.3–70.4)
P (Mann–Whitney U-test) NS NS NS o0.01
Respiratory burst (PMA, MFI)
Patients 123.4 (27.9–187.8) 129.7 (41.6–161.6) NE 85.4 (18.3–125.9) 41.0 (6.6–139.6)
Healthy subjects 212.0 (100.8–415.6) 188.2 (117.9–270.7) NE 152.2 (121.0–220.6) 130.8 (94.6–224.3)
P (Mann–Whitney U-test) o0.01 o0.01 o0.001 o0.001
ANOVA, analysis of variance; fMLP, formyl-methionyl-leucyl-phenylalanine; MFI, mean fluorescence intensity; NE, not examined; NS, nonsignificant; PMA, phorbol 12-myristate
13-acetate.
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Leukocyte apoptosis
In both, the monocytes and granulocytes, we observed no
significant differences in the percentage of apoptotic cells
(Annexin Vþ and Annexin Vþ propidium iodide (PI)þ )
in the peripheral circulation at times 0 and 10 h between
patients and healthy subjects (data not shown). Furthermore,
there were no significant differences in the percentage of
apoptotic cells in the blisters representing intermediate or
intense inflammation between patients and healthy subjects
(data not shown).
DISCUSSION
Patients on hemodialysis have an increased susceptibility to
infectious diseases. Retrospective data indicate that patients
on high-flux hemodialysis and those treated with biocompa-
tible membranes have a lower risk of infections compared
with patients treated with low-flux membranes and bioin-
compatible dialyzers.1,17,18,22
In this study, we show that monocytes and granulocytes
that transmigrate in vivo through the endothelium to sites of
induced inflammation in the interstitium in patients on
high-flux hemodiafiltration or high-flux hemodialysis, have a
preserved capacity to upregulate CD11b, an adhesion
molecule that is important for leukocyte function and
phagocytosis.13,14 Furthermore, leukocytes that transmigrate
to inflammatory sites in the interstitium of patients showed a
preserved capacity to respond to a second signal, for example,
stimulation with fMLP in terms of CD11b expression,
compared with cells from healthy subjects. These findings
are in contrast to our previous observations of impaired
monocyte and granulocyte CD11b expression at sites of
interstitial inflammation in patients on low-flux bioincom-
patible hemodialysis.15,16
The preserved capacity of both monocytes and granulocytes
to express CD11b at the sites of interstitial inflammation in
patients on high-flux hemodiafiltration or high-flux hemo-
dialysis may have important biological consequences in terms
of preserved performance of cytotoxic actions in which the
CD11b molecule plays a key role.23,24 The mechanisms behind
this preserved leukocyte function in patients with high-flux
biocompatible procedures can only be speculated upon. One
possible explanation may be that there is a selective
recruitment of monocytes and granulocytes with a high
CD11b phenotype in patients on high-flux biocompatible
hemodialysis. Another, more plausible, explanation is that
circulating low-molecular plasma factors that accumulate in
the serum of dialysis patients and that have the potential to
inhibit essential functions of leukocytes are removed by high-
flux convective hemodiafiltration or high-flux hemodialysis.
Examples of such potentially inhibitory factors are immuno-
globulin light chains, guanidines, p-cresol, and granulocyte
inhibitory proteins.6,7,8,10,11,12 The determination of such
leukocyte inhibitory factors in plasma in patients on high-
flux dialysis was beyond the scoop of this investigation.
However, it has been suggested that the presence of low
molecular weight inhibitors of leukocytes in the plasma of
end-stage renal disease patients may explain, at least in part,
why infections are the most common cause of hospitalization
and the second most common cause of death in patients with
kidney failure.5,8,12
Granulocytes and monocytes produce reactive oxygen
species as part of the host defense against invading bacteria.
These cells generate reactive species using a multicomponent
enzyme complex, a process referred to as the respiratory
burst. The hemodialysis procedure is associated with an
increase in the production of reactive oxygen species, to a
degree depending on the dialysis membrane material.25 In the
present investigation, there were no significant differences in
the H2O2 production from leukocytes in the peripheral
circulation or at the site of intermediate interstitial
inflammation between patients and healthy subjects. How-
ever, at the site of intense inflammation, the H2O2
production from both monocytes and granulocytes was
significantly lower in patients compared with cells from
healthy subjects. Following stimulation of leukocytes with
fMLP, H2O2 production from both monocytes and granulo-
cytes collected from the site of intermediate inflammation
was similar in patients and healthy subjects. However,
following the most potent stimulation with PMA, the
production of H2O2 from both monocytes and granulocytes
collected from the site of intense inflammation was
significantly lower in cells from patients compared with cells
in healthy subjects. Together these results indicate that
monocytes and granulocytes collected from the peripheral
circulation and in vivo transmigrated cells at the sites of
intermediate inflammation in patients on high-flux hemo-
diafiltration or high-flux hemodialysis have a preserved
capacity to respond with an increase in H2O2 production.
However, following the most potent stimulation with PMA,
both in vivo transmigrated monocytes and granulocytes from
the site of intense inflammation in patients showed a lower
response compared with cells from healthy subjects. This
indicates the presence of a dose–response phenomenon
in terms of leukocyte function in this group of patients.
Our findings are in accordance with results from Ward
et al.26 who found that oxygen radical production from
neutrophils in the peripheral circulation normalizes during
high-flux dialysis. It has been suggested that an unknown
low-molecular-weight factor capable of priming respiratory
burst in granulocytes may be removed by high-flux
hemodialysis.26,27
Clearance of leukocytes via apoptosis from the site of
infection is crucial for the coordinated resolution of
inflammation. The balance between stimulating and attenu-
ating apoptotic factors is necessary for the maintenance of an
effective immune response without the harmful side effects of
neutrophil activation. Previous studies have indicated that
uremia is a state that induces apoptosis, but that this is
normalized with continuous and high-flux blood purification
modalities.28,29 In the present study, neither in blood nor at
the sites of intermediate and intense inflammation were there
any significant differences in monocyte and granulocyte
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apoptosis between cells collected from patients and healthy
subjects. Thus, also in this respect, high-flux procedures seem
to preserve leukocyte function. This is in accordance with
previous studies showing that dialysis membrane character-
istics independently affect leukocyte cell apoptosis.30,31
The impact of the more biocompatible dialysis mem-
branes used in this study, compared with in our previous,15,16
on leukocyte function may be important and remains to be
elucidated. Several previous clinical and experimental studies
have shown that leukocytes collected from patients on
bioincompatible dialyzers are unphysiologically activated in
the peripheral circulation and that this affects leukocyte
function, adherence to endothelial cells and the capacity to
migrate.9,12,21,32,33 However, among the patients in the
randomized controlled hemodialysis (HEMO) study, chronic
high-flux biocompatible hemodialysis did not significantly
affect outcomes, including the rates of infections.3,19,25 By
contrast, recent observational data suggest that hemodiafil-
tration may improve patient survival independent of a higher
dialysis dose.34
In conclusion, this is the first study to show that
monocytes and granulocytes that transmigrate in vivo from
the peripheral circulation to the site of actual action, that is
in the interstitium, in patients on high-flux biocompatible
hemodiafiltration have a preserved capacity to upregulate
CD11b compared with cells from healthy subjects. Further-
more, monocytes and granulocytes in the interstitium were
able to respond to a second signal (fMLP) at the site of
intermediate inflammation. This supports the view that high-
flux biocompatible hemodiafiltration or high-flux hemodia-
lysis may preserve leukocyte function better than low-flux




Ten patients (seven males and three females) with a mean age of 64
years (range, 33–74 years), treated with high-flux hemodiafiltration
(eight patients) or high-flux hemodialysis (two patients) were
included in the study. Demographics, dialysis prescription, dialysis
access, Kt/V, medication and infections are shown in Table 3. All
patients had polysulfone membranes (F80-F100, Fresenius Medical
Care, Germany). None of the patients were suffering from infectious
diseases or active systemic inflammatory diseases and none were
taking antibiotics, anti-inflammatory or immunosuppressive drugs.
Mean hemodialysis time was 1471 h per week and mean Kt/V was
1.770.3. The renal diagnoses were: inactive glomerulonephritis
(four patients), nephrosclerosis (three), interstitial nephritis (two),
and polycystic kidney disease in one patient. Twelve healthy subjects
(six males and six females) with a mean age of 55 years (range, 32–75
years) were also studied. None of the healthy subjects were on any
medication at the time of examination. Informed consent was
obtained from all participants and the study was approved by the
Ethics Committee of the Karolinska University Hospital, Stockholm,
Sweden.
Skin suction chambers and collection of blister fluid
This method has previously been described in detail.15 Briefly, a site
of interstitial inflammation was induced on one of the forearms of
patients and healthy subjects, by use of a skin suction chamber
technique. A vacuum was applied by continuous suction and two
blisters were raised within 2–3 h. The skin blisters were covered and
12–14 h thereafter the roofs were removed after the blister fluid had
been aspirated, pooled, and saved for analysis in 70 C. The first
pool of exudates collected from the two overnight blisters was
designated ‘0 h’. Skin bond cement was then applied around the
bottom edge of sterilized open-bottom plastic skin chambers with a
volume of 1 ml. The skin chambers were placed over the unroofed
blisters and secured. In the proximal chamber, 1 ml of heparinized
autologous serum was added (6ml Heparin added to 1 ml serum).
The autologous serum was collected the day before, centrifuged for
15 min at 41C and immediately frozen at 701C. In the distal
chamber, 1 ml phosphate-buffered saline (PBS) and 6 ml Heparin
were inserted. The administration of serum and buffer in the
respective chambers was carried out in order to induce two degrees
of intensity of the inflammatory stimulus in the blisters. An ‘intense
inflammation’ was induced in the chamber with serum and an
‘intermediate inflammation’ in the chamber containing buffer. The
reason for the nomenclature is based on previously published
data.15,16 Patients were thereafter dialyzed for 4–5 h. After 10 h of
incubation, the blister fluid in the respective skin chamber was
aspirated and placed on ice. The blister fluid was then centrifuged at
1300 r.p.m. for 5 min at 41C and the pellets were resuspended in
500–1000ml of 0.15 M PBS of pH 7.4, supplemented with 0,9 mg/ml
glucose (PBS-glucose) and kept on ice until used for analysis. The





dialysis (years) Type Hours/week Access Kt/V EPO Iv iron Vitamin D Statin Infections during time on dialysis
1 33 2 HDF Pre 30 lit 15 AV-graft 1.7 + + + + Recurrent upper UTI
2 62 2 HD 15 AV-fistula 1.5 + + + + Access-related septicemia
3 69 3 HDF Post 20 lit 16 AV-fistula 1.3  + + Access-related septicemia
4 71 3 HDF Post 25 lit 13.5 AV-fistula 1.8 + + +  Access-related septicemia
5 68 3 HDF Post 24 lit 15 AV-fistula 1.7 + + +  Bacterial bronchitis Virosis
6 72 3 HDF Post 60 lit 13.5 AV-fistula 1.7 + + + + Pneumonia
7 64 5 HDF Post 20 lit 15 AV-fistula 1.7 +  +  Recurrent UTI Streptococci in leg ulcer
8 74 4 HDF Post 24 lit 13.5 AV-fistula 2.4   +  
9 60 6 HD 12.5 AV-fistula 1.8 +  +  
10 63 7 HDF Post 14 lit 13.5 CDC 1.4 + + +  
CDC, central dialysis catheter; EPO, erythropoietin; HD, high-flux hemodialysis; HDF, hemodiafiltration (Pre, pre-dilution; Post, post-dilution, volume in litres); UTI, urinary tract
infection.
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reason for choosing 10 h of incubation was based on previous
studies in which we and others have observed that a sufficient
number of cells transmigrate during 10 h.15,16,35
Collection of blood samples
Blood samples were drawn in the morning from patients and healthy
subjects, when the first pool of blister exudates was collected (see
above) and 10 h thereafter. Samples were collected in tubes
containing citrate (Vacutainer, 5 ml, with 0.129 M Na-citrate Becton
Dickinson, Plymouth, UK). Blood samples were kept on ice to
prevent further complement activation and modulation of adhesion
molecule expression on monocytes and granulocytes.
Preparation of peripheral leukocytes
Erythrocytes were hemolyzed by addition of 2 ml 41C isotonic
NH4Cl-ethylenediaminetetraacetic acid ‘lysing solution’ (containing
154 mM NH4Cl, 10 mM KHCO3, and 0.1. mM ethylenediaminete-
traacetic acid, pH 7.2) to 100 ml blood. The samples were incubated
at 41C for 5 min and then centrifuged at 1300 r.p.m. for 5 min at 41C
to produce a leukocyte pellet. The leukocytes were finally washed in
2 ml 41C PBS-glucose and centrifuged. Cells to be used for
immunostaining were resuspended in 100ml cold PBS with the
addition of 0.02% sodium azide (PBS-azide) and cells to be analyzed
for respiratory burst were resuspended with 100ml cold PBS-glucose.
The cells were kept on ice during handling and the experiments were
performed within 30 min to avoid further cell activation.
Number of leukocytes in the peripheral circulation and at the
sites of interstitial inflammation
In the blister exudates the number of monocytes and granulocytes
were counted using a flow cytometer (Epics Elite, Beckman Coulter
Inc., Hialeah, FL, USA). To determine the number of leukocytes in
the peripheral circulation, 100 ml blood was hemolyzed, stabilized
and fixed according to the Multi-Q-prep, ImmunoPrep technique
(Beckman Coulter Inc.) and the cells were counted by flow
cytometry (Beckman Coulter Inc.).
Analysis of leukocyte CD11b expression
Leukocytes from patients and healthy subjects were isolated from
blood at 0 and 10 h and from the blister fluid at time 0 h,
intermediate inflammation and intense inflammation at 10 h. In
order to study the ability of leukocytes to respond to a second signal,
monocytes and granulocytes were activated in the presence of 200 ml
0,5mM fMLP (Sigma Chemical Co., Dorsett, UK) for 15 min at 371C.
Monocytes and granulocytes incubated with RPMI 1640 medium
supplemented with 0.01 mmol/l N-2-hydroxyethylpiperazine-N0-2-
ethanesulfonic acid (HEPES-RPMI-buffer, Gibco Ltd, Paisley,
Renfrewshire, UK/Invitrogen AB) and 5% heat-inactivated fetal
bovine serum for 15 min at 41C, served as a negative control. Cells
were then washed with 2 ml cold PBS-azide and centrifuged at
1300 r.p.m. at 41C for 5 min. The supernatant was removed and the
cells were resuspended in 100ml PBS-azide. Five microliter of
phycoerythrin-conjugated monoclonal mouse anti-human CD11b,
C3bi receptor/RPE (Clone 2LPM19c, Dako AS, Glostrup,
Denmark) was added to each sample before incubation for 30 min
on ice. The cells were then washed with 2 ml cold PBS-azide,
centrifuged at 1300 r.p.m. at 41C for 5 min and the pellets were
finally resuspended in 500 ml cold PBS-azide before analysis by flow
cytometry. Using flow cytometry, the density of the adhesion
molecule expression of granulocytes and monocytes was presented
as mean fluorescence intensity of the gated leukocyte population
within a chosen field.
Measurement of respiratory burst
Cells were isolated from blood at times 0 and 10 h and from the
blister fluid representing intermediate inflammation or intense
inflammation at 10 h and were incubated with 5 mM 20,70-dichloro-
fluorescein diacetate (Fluka 35847, Sigma Chemical Co., Dorsett,
UK) in PBS-glucose for 15 min at 371C. The samples were gently
shaken at least three times during the incubation in order to get a
proper permeabilization of 20,70-dichlorofluorescein diacetate and to
avoid cell aggregation. Following incubation with 20,70-dichloro-
fluorescein diacetate, granulocytes and monocytes were stimulated
with either 200 ml 0.5 mM PMA (D-5879, Sigma Chemical Co.,
Dorsett, UK) in PBS-glucose (receptor-independent stimulus) or
200 ml 0.5mM fMLP (receptor-dependent stimulus) in PBS-glucose
and incubated for 15 or 30 min, respectively, at 371C. Cells
incubated with 200ml PBS-glucose alone for 15 min on ice were
used as a negative control. The samples were gently shaken three
times during the incubation. After incubation, the cell suspensions
were placed on ice and 1 ml cold PBS-azide supplemented with
0.1 mM ethylenediaminetetraacetic acid was added to stop the
reaction. The samples were analyzed immediately by flow cytometry
and the amount of H2O2 formation, indirectly expressed as green
fluorescence from the DCF molecules, was expressed as mean
fluorescence intensity of the gated leukocyte population within a
chosen field.
Analysis of leukocyte apoptosis
Monocytes and granulocytes from patients and healthy subjects were
analyzed as to the percentage of apoptotic cells in the two different
cell populations. Cells were isolated from blood at the two time
points (0 and 10 h) and from the blisters representing intermediate
and intense inflammation. We used the Annexin V kit from BD
Biosciences (IM3546), which makes it possible to stain the cells both
with Annexin V and PI. Simultaneous staining with Annexin V and
PI serves to define cells that are in an intact viable state, an early
apoptotic state and a late apoptotic or necrotic state, respectively.
This is expressed as negative staining for both Annexin V and PI,
positive staining for Annexin V but not for PI and positive staining
for both Annexin V and PI, respectively. Cells were stained according
to the manufacturer’s instructions and immediately analyzed by flow
cytometry. The percentage of early and late apoptotic cells was
calculated for the two leukocyte populations.
Statistical analysis
Results are expressed as mean7s.d. for the normally distributed
data (CD11b) and as median and range for the non-parametric data.
Statistical analysis was performed using ANOVA for repeated
measurements and the post hoc Scheffe´ test for the CD11b analyses.
Mann–Whitney U-test for two independent samples was used to
analyze the data for the hydrogen peroxide formation and apoptosis,
as results were not normally distributed and the variances were not
homogenous.
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